Literature DB >> 23024426

Inability to replicate cerebrospinal fluid histamine deficits in the primary hypersomnias: a back to the drawing board moment.

David B Rye.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23024426      PMCID： PMC3443754          DOI： 10.5665/sleep.2098

Source DB:  PubMed          Journal:  Sleep        ISSN： 0161-8105            Impact factor:   5.849


× No keyword cloud information.
  26 in total

1.  Humoral Regulation of Sleep.

Authors:  James M. Krueger; Jidong Fang; Michael K. Hansen; Jianyi Zhang; Ferenc Obál
Journal:  News Physiol Sci       Date:  1998-08

2.  Excessive daytime sleepiness: population and etiology versus nosology.

Authors:  Emmanuel Mignot
Journal:  Sleep Med Rev       Date:  2008-04       Impact factor: 11.609

3.  Is low histamine a fundamental cause of sleepiness in narcolepsy and idiopathic hypersomnia?

Authors:  Thomas E Scammell; Takatoshi Mochizuki
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

Review 4.  Histamine and orexin in the control of arousal, locomotion, and motivation.

Authors:  Christian R Burgess
Journal:  J Neurosci       Date:  2010-02-24       Impact factor: 6.167

5.  Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions.

Authors:  Yves Dauvilliers; Nathalie Delallée; Isabelle Jaussent; Sabine Scholz; Sophie Bayard; Mickael Croyal; Jean-Charles Schwartz; Philippe Robert
Journal:  Sleep       Date:  2012-10-01       Impact factor: 5.849

Review 6.  Histamine in the regulation of wakefulness.

Authors:  Mahesh M Thakkar
Journal:  Sleep Med Rev       Date:  2010-09-20       Impact factor: 11.609

7.  Effects of lesions of the histaminergic tuberomammillary nucleus on spontaneous sleep in rats.

Authors:  Dmitry Gerashchenko; Thomas C Chou; Carlos A Blanco-Centurion; Clifford B Saper; Priyattam J Shiromani
Journal:  Sleep       Date:  2004-11-01       Impact factor: 5.849

8.  Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.

Authors:  Seiji Nishino; Eiko Sakurai; Sona Nevsimalova; Yasushi Yoshida; Takehiko Watanabe; Kazuhiko Yanai; Emmanuel Mignot
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

9.  The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.

Authors:  R Parmentier; C Anaclet; C Guhennec; E Brousseau; D Bricout; T Giboulot; D Bozyczko-Coyne; K Spiegel; H Ohtsu; M Williams; J S Lin
Journal:  Biochem Pharmacol       Date:  2007-01-07       Impact factor: 5.858

10.  Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms.

Authors:  G D Prell; J P Green; C A Kaufmann; J K Khandelwal; A M Morrishow; D G Kirch; M Linnoila; R J Wyatt
Journal:  Schizophr Res       Date:  1995-01       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.